Softbank Vision FUND (aiv M1) L.P., 10% Owner at Vir Biotechnology, Inc. (VIR), sold 305,626 shares at $29.50 ($9.0M) on 2023-01-31, disclosed to the SEC on 2023-02-01.
Open-market sale of $9.0M VIR by 10% Owner. Not flagged as scheduled, tax-driven, or recurring — but no specific bearish signal from our filters. Reasons for insider sales vary widely.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $29.32 | 67,026 | $2.0M | 21.8% |
| 2 | $29.32 | 67,026 | $2.0M | 21.8% |
| 3 | $30.21 | 11,904 | $360K | 4.0% |
| 4 | $30.21 | 11,904 | $360K | 4.0% |
| 5 | $28.88 | 3,316 | $96K | 1.1% |
| 6 | $28.88 | 3,316 |
| $96K |
| 1.1% |
| 7 | $29.50 | 70,567 | $2.1M | 23.1% |
| 8 | $29.50 | 70,567 | $2.1M | 23.1% |
| Total | $29.46 avg | 305,626 | $9.0M | 100% |
| Filing → |
| VIR | SELL | 2023-07-05 | $18K | — | Filing → |
| COMP | SELL | 2023-06-09 | $55.4M | — | Filing → |
| VIR | SELL | 2023-04-18 | $1.0M | — | Filing → |